Experimental Steps and Data Analysis Strategies of De Novo Protein Sequencing
De Novo Protein Sequencing is a technique that directly deciphers the complete amino acid sequence of the target protein from experimental data without relying on known genomes or protein databases. This technology is widely used in the discovery of novel biomarkers, development of antibody drugs, and research of non-model organisms. It is particularly important for the study of unknown proteins (such as newly discovered biomarkers, antibody drug variable regions) or proteins from species lacking genomic annotation. Its core involves capturing fragment ion information of enzymatically digested peptides through mass spectrometry and deducing sequences using algorithms. The experimental design and data analysis directly affect the accuracy and reliability of the results.
I. Experimental Steps
1. Sample Preparation
In the process of De Novo Protein Sequencing, the quality of the sample directly affects the accuracy of mass spectrometry analysis. Sample preparation includes the following key steps:
(1) Obtain high-purity proteins through methods such as ultrasonic disruption, immunoaffinity purification, or gel electrophoresis.
(2) Conduct protein concentration determination to ensure that the protein amount is suitable for subsequent enzymatic digestion.
(3) Use DTT (DL-Dithiothreitol) and IAA (Iodoacetamide) for thiol blocking to prevent interference from protein disulfide bonds.
2. Enzymatic Digestion Strategy
Since De Novo Protein Sequencing relies on the accurate analysis of peptides by mass spectrometry, a reasonable enzymatic digestion strategy is crucial. Common strategies include:
(1) Single Enzymatic Digestion: Use Trypsin to specifically cleave the C-terminal side of lysine (K) and arginine (R) residues to improve peptide uniformity.
(2) Multiple Enzymatic Digestion: Combine different enzymes like Lys-C, Asp-N to improve protein coverage, obtain peptides of different lengths, and enhance the reliability of mass spectrometry analysis.
(3) Non-Enzymatic Cleavage: Use chemical degradation (such as CNBr cleavage of methionine) or physical methods (such as laser desorption) to complement enzymatic digestion insufficiencies.
3. Liquid Chromatography Separation (LC-MS)
(1) Use High-Performance Liquid Chromatography (HPLC) or Ultra-High-Performance Liquid Chromatography (UHPLC) to separate enzymatically digested peptides and reduce co-elution interference.
(2) Combine with nano-scale Liquid Chromatography (nano-LC) to increase sensitivity, suitable for analyzing low-abundance proteins.
4. High-Resolution Mass Spectrometry Analysis (MS/MS)
(1) Use high-resolution mass spectrometers (such as Orbitrap, Q-TOF, FT-ICR MS) for peptide mass spectrometry detection.
(2) Combine multiple fragmentation modes, such as CID (Collision-Induced Dissociation), HCD (Higher-Energy Collisional Dissociation), and ETD (Electron Transfer Dissociation), to enhance ion fragmentation coverage and improve sequence analysis capability.
II. Data Analysis Strategies
Data analysis in De Novo Protein Sequencing relies on efficient computational methods, primarily including raw data processing, sequence deduction, and result validation.
1. Data Preprocessing
(1) Perform baseline correction, noise reduction, and mass calibration to ensure data accuracy.
(2) Optimize fragment ion matching through dynamic window adjustment to improve signal-to-noise ratio.
2. Sequence Deduction Algorithm Optimization
Currently, the commonly used algorithms for De Novo Protein Sequencing include:
(1) Graph Theory-based Peaks Algorithm: Use the mass difference between ion peaks to deduce amino acid sequences, suitable for high-resolution data.
(2) Deep Learning-based DeepNovo: Improve low signal-to-noise ratio data recognition ability by learning mass spectrometry data features through neural network models.
(3) Database-assisted Hybrid Method: Combine known sequence information to improve the accuracy of complex peptide analysis.
3. Sequence Integrity Validation
(1) Use secondary mass spectrometry (MS2) data for b/y ion matching to improve the reliability of results.
(2) Combine with Post-Translational Modifications (PTMs) analysis to ensure correct interpretation of modified proteins.
(3) Further validate sequence accuracy using bioinformatics tools like BLAST or UniProt databases.
III. Optimization Directions
With advancements in high-resolution mass spectrometry technology and computational analysis methods, De Novo Protein Sequencing is moving towards higher precision and high-throughput development. Future optimization directions include:
(1) Combine single-cell proteomics to decipher sequence information of trace proteins.
(2) Use quantum computing and artificial intelligence to enhance computational efficiency in sequence prediction.
(3) Develop more efficient fragmentation modes, such as EAD (Electron Capture Dissociation), to enhance sequence coverage.
Optimization research in De Novo Protein Sequencing involves improvements in experimental methods and enhancements in data analysis strategies. By continuously optimizing experimental processes and computational algorithms, this technology will play a role in basic research, precision medicine, and biopharmaceutical fields. Bethel Biotech provides high-quality sequencing services, feel free to contact us!
Bethel Biotech - Characterization of Bioproducts, Quality Service Provider for Multi-Omics Mass Spectrometry Detection
Related Services:
How to order?
